These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 24053651

  • 21. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A, Fritsche HM, Gakis G, Kluth LA, Hassan Fa, Engel O, Dahlem R, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Shariat SF, Fisch M, Burger M, Rink M.
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [Abstract] [Full Text] [Related]

  • 22. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A, Kuehhas FE, Gayed BA, Wood CG, Raman JD, Kapur P, Derweesh IH, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.
    Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
    [Abstract] [Full Text] [Related]

  • 23. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Hurel S, Rouprêt M, Ouzzane A, Rozet F, Xylinas E, Zerbib M, Berod AA, Ruffion A, Adam E, Cussenot O, Houlgatte A, Phé V, Nouhaud FX, Bensadoun H, Delage F, Guillotreau J, Guy L, Karsenty G, De La Taille A, Colin P, French Collaborative National Database on UTUC.
    BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
    [Abstract] [Full Text] [Related]

  • 24. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
    Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF, French National Database on Upper Tract Tumors, Upper Tract Urothelial Carcinoma Collaboration.
    J Urol; 2013 May; 189(5):1662-9. PubMed ID: 23103802
    [Abstract] [Full Text] [Related]

  • 25. Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Shirotake S, Hayakawa N, Kosaka T, Miyajima A, Momma T, Nakagawa K, Hasegawa S, Nakajima Y, Oya M.
    BJU Int; 2013 Jul; 112(2):E28-34. PubMed ID: 23795795
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F.
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [Abstract] [Full Text] [Related]

  • 29. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Bumbasirevic U, Vukovic I, Dragicevic D, Tulic C.
    BJU Int; 2012 Apr; 109(7):1037-42. PubMed ID: 21883837
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
    Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF.
    BJU Int; 2011 Aug; 108(3):406-12. PubMed ID: 21078048
    [Abstract] [Full Text] [Related]

  • 32. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
    Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, Montorsi F, Bolenz C, Weizer AZ, Wheat JC, Ng CK, Scherr DS, Remzi M, Waldert M, Wood CG, Margulis V, Upper-Tract Urothelial Carcinoma Collaborative Group.
    Urol Oncol; 2011 Aug; 29(6):716-23. PubMed ID: 20056458
    [Abstract] [Full Text] [Related]

  • 33. A delay in radical nephroureterectomy can lead to upstaging.
    Waldert M, Karakiewicz PI, Raman JD, Remzi M, Isbarn H, Lotan Y, Capitanio U, Bensalah K, Marberger MJ, Shariat SF.
    BJU Int; 2010 Mar; 105(6):812-7. PubMed ID: 19732052
    [Abstract] [Full Text] [Related]

  • 34. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF.
    BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
    [Abstract] [Full Text] [Related]

  • 35. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML, Stewart GD, Wells-Cole S, Phipps S, Thomas BG, Tolley DA.
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB, Chang LL, Cheng KI, Huang CH, Kwan AL.
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [Abstract] [Full Text] [Related]

  • 38. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H.
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.